Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP238060.RAU9vCLY_rGa91tyzYrgs_veGgGa4XfAbvTlLfaGSXNPY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP238060.RAU9vCLY_rGa91tyzYrgs_veGgGa4XfAbvTlLfaGSXNPY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP238060.RAU9vCLY_rGa91tyzYrgs_veGgGa4XfAbvTlLfaGSXNPY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP238060.RAU9vCLY_rGa91tyzYrgs_veGgGa4XfAbvTlLfaGSXNPY130_provenance.
- NP238060.RAU9vCLY_rGa91tyzYrgs_veGgGa4XfAbvTlLfaGSXNPY130_assertion description "[Oncolytic measles virus (MV) encoding the human thyroidal sodium iodide symporter (MV-NIS) has proved to be safe after intraperitoneal or intravenous administration in patients with ovarian cancer or multiple myeloma, respectively, but it has not yet been administered through intratumoral injection in humans.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP238060.RAU9vCLY_rGa91tyzYrgs_veGgGa4XfAbvTlLfaGSXNPY130_provenance.
- NP238060.RAU9vCLY_rGa91tyzYrgs_veGgGa4XfAbvTlLfaGSXNPY130_assertion evidence source_evidence_literature NP238060.RAU9vCLY_rGa91tyzYrgs_veGgGa4XfAbvTlLfaGSXNPY130_provenance.
- NP238060.RAU9vCLY_rGa91tyzYrgs_veGgGa4XfAbvTlLfaGSXNPY130_assertion SIO_000772 22235810 NP238060.RAU9vCLY_rGa91tyzYrgs_veGgGa4XfAbvTlLfaGSXNPY130_provenance.
- NP238060.RAU9vCLY_rGa91tyzYrgs_veGgGa4XfAbvTlLfaGSXNPY130_assertion wasDerivedFrom befree-20140225 NP238060.RAU9vCLY_rGa91tyzYrgs_veGgGa4XfAbvTlLfaGSXNPY130_provenance.
- NP238060.RAU9vCLY_rGa91tyzYrgs_veGgGa4XfAbvTlLfaGSXNPY130_assertion wasGeneratedBy ECO_0000203 NP238060.RAU9vCLY_rGa91tyzYrgs_veGgGa4XfAbvTlLfaGSXNPY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP238060.RAU9vCLY_rGa91tyzYrgs_veGgGa4XfAbvTlLfaGSXNPY130_provenance.